Health Care: Drugs

Supernus Pharmaceuticals Inc (SUPN: NASDAQ)

$12.82 n/a | n/a%
05/01/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 12.82
52 Week High 14.07
52 Week Low 7.09
Avg. Daily Vol. (Mil) 0.60
Beta (3 year) 0.82
Share Related Items
Mkt Cap (Mil) 599.71
Shares Out (Mil) 44.09
Float (Mil) 34.33
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.30
Current Ratio 4.00
LT Debt/ Equity 0.38
Total Debt / Equity 0.38
Valuation Ratios
Price Earnings 32.60
Price/Sales 4.63
Price/Book 7.92
Price/Cash Flow 24.70
Per Share Data
Earnings 0.39
Sales 2.77
Book Value 1.62
Cash Flow 0.52
Business Summary
Supernus Pharmaceuticals Incis a specialty pharmaceutical company. The Company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders.
General Information
1550 East Gude Drive
Rockville, MD 20850
Industry : Drugs
Sector: Health Care
Employees: 309
CEO: Jack Khattar
Short Interest
Current Month (Mil) 2.18
Previous Month (Mil) 2.11
Short Interest Ratio (Days) 3.10
Management Effectiveness
Return on Equity 27.80
Return on Assets 14.50
Return on Investments 20.20
Gross Margin 97.80
EBIT Margin 20.30
Profit Margin 16.30

Portfolios with SUPN

Latest SUPN Headlines from TheStreet

More Financial News for SUPN

Press Releases for SUPN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter